The worldwide outbreak of COVID-19 was caused by a pathogenic virus called Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Therapies against SARS-CoV-2 target the virus or human cells or the immune system. However, therapies based on specific antibodies, such as vaccines and monoclonal antibodies, may become inefficient enough when the virus changes its antigenicity due to mutations. Polyphenols are the major class of bioactive compounds in nature, exerting diverse health effects based on their direct antioxidant activity and their effects in the modulation of intracellular signaling. There are currently numerous clinical trials investigating the effects of polyphenols in prophylaxis and the treatment of COVID-19, from symptomatic, via moderate and severe COVID-19 treatment, to anti-fibrotic treatment in discharged COVID-19 patients. Antiviral activities of polyphenols and their impact on immune system modulation could serve as a solid basis for developing polyphenol-based natural approaches for preventing and treating COVID-19.
【저자키워드】 SARS-CoV-2, antiviral effects, polyphenols, antiviral targets, 【초록키워드】 COVID-19, Treatment, Vaccine, clinical trial, therapy, severe COVID-19, mutations, severe acute respiratory syndrome coronavirus-2, immune system, severe acute respiratory syndrome Coronavirus, monoclonal antibodies, virus, antioxidant, activity, Prophylaxis, Severe acute respiratory syndrome, Health, outbreak, symptomatic, antigenicity, respiratory, polyphenol, change, moderate, COVID-19 patients, specific antibodies, antiviral activities, acute respiratory syndrome, treatment of COVID-19, modulation, Compound, human cells, treating COVID-19, human cell, intracellular signaling, pathogenic virus, Effect, approach, caused, discharged, inefficient, 【제목키워드】 COVID-19, protection, prevention, Compound, Action,